Extracellular matrix alterations in cardiomyopathy: The possible crucial role in the dilative form

Experimental and Clinical Cardiology

Volumn 6, Issue 1, 2001, Pages 41-49

  Kapelko, V I ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Cardiomyopathy; Extracellular matrix; Fibrosis; Heart; Remodelling

Indexed keywords

ACTIN; DOXORUBICIN; DYSTROPHIN; MEROSIN; SCLEROPROTEIN;

ACTIN FILAMENT; ALCOHOL CONSUMPTION; CARDIOMYOPATHY; CELL ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; EXTRACELLULAR MATRIX; FAMILIAL DISEASE; GENE MUTATION; HEART DILATATION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; PROTEIN ANALYSIS; RESTRICTIVE CARDIOMYOPATHY; REVIEW; TISSUE REPAIR;

EID: 0035048210     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. The myocardial interstitium: Its structure and its role in ionic exchange
2. Ventricular remodeling
3. Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy
4. Collagen in dilated cardiomyopathy - Scanning electron microscopic and immunohistochemical observations
5. The extracellular matrix in the failing human heart
6. Collagen subtypes and matrix metalloproteinase in idiopathic restrictive cardiomyopathy
7. Interactions between cardiomyocytes and extracellular matrix in the failing human heart
8. Extracellular matrix components in dilated cardiomyopathy. Immunohistochemical study of endomyocardial biopsy specimens
9. Changes in extracellular matrix components in cardiomyopathic Syrian hamster, BIO 14.6
10. Myocardial connective tissue alterations
11. Proteoglycans: An overview
12. Integrins, adhesion, and cardiac remodeling
13. 2-terminal kinase activation by mechanical stretch is integrin-dependent and matrix-specific in rat cardiac fibroblasts
14. Fibronectin, laminin, and other extracellular glycoproteins
15. Vinculin is an essential component for normal myofibrillar arrangement in fetal mouse cardiac myocytes
16. Spectrin in developing normal and cardiomyopathic hamster heart
17. A 5′ dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy
18. Evidence of left ventricular dysfunction in children with merosin-deficient congenital muscular dystrophy
19. Factors affecting cardiac cell shape
20. Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure
21. Effects of enalapril on the collagen matrix in cardiomyopathic Syrian hamsters (Bio 14.6 and 53.58)
22. Alteration of extracellular matrix in dilated cardiomyopathic hamster heart
23. Cardiac interstitium in health and disease: The fibrillar collagen network
24. Enhanced deposition of predominantly type I collagen in myocardial disease
25. Local regulation of extracellular matrix structure
26. Renin-angiotensin system in failing heart
27. Isolation of rat heart endothelial cells and pericytes: Evaluation of their role in the formation of extracellular components
28. Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease
29. Extracellular matrix remodeling in heart failure: A role for de novo angiotensin II generation
30. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts
31. Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium
32. Transforming growth factor-β in disease: The dark side of tissue repair
33. Molecular mechanisms and therapeutic strategies related to nitric oxide
34. Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats
35. Pharmacological modulation of cardiac fibroblast function
36. Renin-angiotensin system and myocardial collagen matrix: Modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism
37. 1 receptor subtype
38. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart
39. 2-receptor subtypes in hypertrophied rat hearts
40. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis
41. Estrogen enhances proliferative capacity of cardiac fibroblasts by estrogen receptor- and mitogen-activated protein kinase-dependent pathways
42. Identification of functional angiotensin II receptors on rat cardiac fibroblasts
43. Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase
44. Endothelial cells regulate cardiac contractility
45. Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart
46. Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats
47. Collagen characterization in volume-overload- and pressure-overload-induced cardiac hypertrophy in minipigs
48. Extracellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblast cells
49. Myocardial fibrin deposition in experimental viral myocarditis that progresses to dilated cardiomyopathy
50. Extracellular matrix remodelling after coxsackievirus B3-induced murine myocarditis
51. The extracellular matrix and cytoskeleton of the myocardium in cardiac inflammatory reaction
52. Expression of inducible nitric oxide synthase in failing and non-failing human heart
53. Captopril suppresses interstitial fibrin deposition in coxsackievirus B3 myocarditis
54. Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy
55. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy
56. Cardiac collagen remodeling in the cardiomyopathic Syrian hamster and the effect of losartan
57. Tissue angiotensin I-converting enzyme activity in aging hamsters with and without cardiomyopathy
58. Cellular mechanisms of captopril-induced matrix remodeling in Syrian hamster cardiomyopathy
59. Development of heart failure following isoproterenol administration in the rat: Role of the renin-angiotensin system
60. Effects of angiotensin-converting enzyme inhibitor and aldosterone antagonist on myocardial collagen in cardiomyopathic hamster
61. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1
62. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction
63. Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes
64. The molecular and cellular biology of heart failure
65. Exclusion of genes coding for proteins of the cytoskeleton and the extracellular matrix in familial HCM using a candidate gene approach
66. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?
67. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex
68. The permissive role of catecholamines in the pathogenesis of hamster cardiomyopathy
69. Upregulation of alpha1A- and alpha1B-adrenergic receptor mRNAs in the heart of cardiomyopathic hamsters
70. Effect of manidipine hydrochloride, a calcium antagonist, on isoproterenol-induced left ventricular hypertrophy
71. Myocardial collagen degradation: Morphological and biochemical correlation
72. Collagen VI in the extracellular matrix of normal and failing human myocardium
73. Tenascin expression in endomyocardial biopsy specimens in patients with dilated cardiomyopathy: Distribution along margin of fibrotic lesions
74. Morphoregulatory interactions of endocardial endothelium and extracellular material in the heart
75. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy
76. Differential gene expression of extracellular matrix components in dilated cardiomyopathy
77. Hereditary dilated cardiomyopathy
78. Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster
79. Defective association of dystrophin with sarcolemmal glycoproteins in the cardiomyopathic hamster heart
80. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy
81. Identification of the Syrian hamster cardiomyopathy gene
82. Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy
83. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure
84. Disruption of cell-cell adhesion in an inbred strain of hereditary cardiomyopathic hamster (Bio 14.6)
85. Chronic congestive heart failure is associated with a phenotypic shift of intramyocardial endothelial cells
86. Alcohol and myocarditis
87. Subcellular effects of adriamycin in the heart: A concise review
88. Extracellular matrix arrangement in the papillary muscles of the adult rat heart. Alterations after doxorubicin administration and experimental hypertension
89. Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans
90. The cellular basis of dilated cardiomyopathy in humans
91. Matrix remodelling in dilated cardiomyopathy entails the occurrence of oncofetal fibronectin molecular variants
92. An investigation of the collagen in cardiomyopathic hamsters
93. Ischemic cardiomyopathy: Pathophysiologic mechanisms
94. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation